• Investing Ideas
  • /
  • South Korean Pharmaceuticals & Biotech Potentially Undervalued Companies
31 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A214450

PharmaResearch
₩130,800.00-10.5%0.6%₩1.3t₩187,500.00PE17.7xE21.1%0.7%

A185750

Chong Kun Dang Pharmaceutical
₩106,700.002.1%27.6%₩1.4t₩152,333.33PE6.7xE-21.8%1.0%

A069620

Daewoong Pharmaceutical
₩109,000.002.0%-2.2%₩1.3t₩159,375.00PE11xE3.2%0.6%

A038290

Macrogen
₩20,700.003.5%2.0%₩206.6b₩30,000.00PS1.6xE125.9%1.4%

A243070

Huons
₩33,200.006.6%2.5%₩394.2b₩54,000.00PE8.5xE11.1%2.0%

A003850

Boryung
₩10,340.000.6%17.8%₩686.6b₩15,333.33PE13.1xE23.5%1.0%

A003220

Daewon Pharmaceutical
₩14,730.001.4%2.4%₩312.2b₩21,000.00PE13.3xE24.7%2.4%

A249420

Ildong Pharmaceutical
₩13,870.001.7%-27.6%₩387.4b₩25,000.00PB2.3xE75.1%0%

A023910

Daihan PharmaceuticalLtd
₩28,700.00-1.2%0.2%₩168.8b₩40,500.00PE5.9xE7.7%2.6%

A086890

ISU Abxis
₩7,080.009.8%-0.6%₩251.6b₩8,000.00PS3.9xE97.0%n/a

A086450

DongKook Pharmaceutical
₩19,000.00-1.3%19.7%₩835.3b₩24,000.00PE16.4xE15.2%0.9%

A080720

Union Korea Pharm
₩5,540.000%-4.0%₩40.0bn/aPB1.5xn/an/a

A086900

Medy-Tox
₩138,900.006.4%-47.6%₩934.8b₩296,000.00PE534xE78.7%0.8%

A000640

Dong-A Socio Holdings
₩101,800.000.9%9.2%₩636.3b₩155,000.00PE11.5xE19.0%2.4%

A420570

J2KBIO
₩29,750.00-7.9%n/a₩165.3bn/aPS5.4xn/a0%

A318160

Cell Bio Human Tech
₩3,940.00-7.4%-46.8%₩36.5bn/aPS1.3xn/an/a

A006280

GC Biopharma
₩119,900.004.5%-2.7%₩1.4t₩146,333.33PB1.1xE83.8%1.3%

A216080

JETEMA
₩16,540.005.6%-12.3%₩295.4b₩28,000.00PE20.8xE44.1%n/a

A170900

Dong-A ST
₩64,300.006.5%21.9%₩559.5b₩80,957.52PB0.9xE65.2%1.1%

A001630

Chong Kun Dang Holdings
₩55,900.00-1.1%13.4%₩266.1b₩63,000.00PE6.1xE-65.7%2.5%

A377740

BioNote
₩4,170.001.6%-23.5%₩425.6bn/aPE22.2xn/a11.8%

A044960

Eagle Veterinary TechnologyLtd
₩5,300.000.6%-10.5%₩67.0bn/aPE23.1xn/a0.8%

A950200

Psomagen
₩4,690.00-1.4%-34.1%₩90.2bn/aPS2.7xn/an/a

A096530

Seegene
₩20,650.00-2.4%-14.7%₩950.8b₩25,000.00PS2.6xE129.2%3.9%
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.